Published in PLoS One on February 24, 2015
PLINK: a tool set for whole-genome association and population-based linkage analyses. Am J Hum Genet (2007) 209.92
Primer3 on the WWW for general users and for biologist programmers. Methods Mol Biol (2000) 128.08
A method and server for predicting damaging missense mutations. Nat Methods (2010) 78.53
SIFT: Predicting amino acid changes that affect protein function. Nucleic Acids Res (2003) 52.26
Predicting deleterious amino acid substitutions. Genome Res (2001) 28.95
Trajectories of growth among children who have coronary events as adults. N Engl J Med (2005) 7.29
Pre-eclampsia and risk of cardiovascular disease and cancer in later life: systematic review and meta-analysis. BMJ (2007) 6.73
SNPper: retrieval and analysis of human SNPs. Bioinformatics (2002) 3.30
Genetic and functional analyses of membrane cofactor protein (CD46) mutations in atypical hemolytic uremic syndrome. J Am Soc Nephrol (2006) 2.88
Mutations in human complement regulator, membrane cofactor protein (CD46), predispose to development of familial hemolytic uremic syndrome. Proc Natl Acad Sci U S A (2003) 2.79
Membrane cofactor protein (MCP or CD46) is a cellular pilus receptor for pathogenic Neisseria. Mol Microbiol (1997) 2.67
Contemporary concepts of the pathogenesis and management of preeclampsia. JAMA (2002) 2.36
Complement activation and inhibition: a delicate balance. Trends Immunol (2009) 2.22
[Characteristic of recent fetal growth curves in Finland]. Duodecim (1989) 1.96
Dissecting sites important for complement regulatory activity in membrane cofactor protein (MCP; CD46). J Biol Chem (2000) 1.84
GENOMEMASKER package for designing unique genomic PCR primers. BMC Bioinformatics (2006) 1.74
Measles virus and C3 binding sites are distinct on membrane cofactor protein (CD46). Proc Natl Acad Sci U S A (1995) 1.64
Membrane cofactor protein mutations in atypical hemolytic uremic syndrome (aHUS), fatal Stx-HUS, C3 glomerulonephritis, and the HELLP syndrome. Blood (2007) 1.53
Mutations in complement regulatory proteins predispose to preeclampsia: a genetic analysis of the PROMISSE cohort. PLoS Med (2011) 1.52
Role of membrane cofactor protein (CD46) in regulation of C4b and C3b deposited on cells. J Immunol (2002) 1.51
Three-dimensional structure of a complement control protein module in solution. J Mol Biol (1991) 1.44
Activation of the complement system in normal pregnancy and preeclampsia. Mol Immunol (2010) 1.37
Maternal urinary tract infection: is it independently associated with adverse pregnancy outcome? J Matern Fetal Neonatal Med (2009) 1.36
Human herpesvirus 6 variant A but not variant B induces fusion from without in a variety of human cells through a human herpesvirus 6 entry receptor, CD46. J Virol (2002) 1.31
Redefining preeclampsia using placenta-derived biomarkers. Hypertension (2013) 1.30
Negligible role of antibodies and C5 in pregnancy loss associated exclusively with C3-dependent mechanisms through complement alternative pathway. Immunity (2003) 1.08
Maternal and fetal alternative complement pathway activation in early severe preeclampsia. Am J Reprod Immunol (2013) 0.89
Characterization of human membrane cofactor protein (MCP; CD46) on spermatozoa. Mol Reprod Dev (2002) 0.89
Functional analysis of the mannose-binding lectin complement pathway in normal pregnancy and preeclampsia. J Reprod Immunol (2010) 0.86
Studies suggest an association between maternal periodontal disease and pre-eclampsia. Evid Based Dent (2008) 0.85
Restriction analysis of otosclerosis-associated CD46 splicing variants. Eur Arch Otorhinolaryngol (2009) 0.80